TY  - JOUR
AU  - Rey, Esther
AU  - Ampuero, Javier
AU  - Molina-Jiménez, Francisca
AU  - Marañón, Patricia
AU  - García-García, Yaiza
AU  - Múñoz-Hernández, Rocío
AU  - Romero-Gómez, Manuel
AU  - García-Monzón, Carmelo
AU  - Majano, Pedro
AU  - González-Rodríguez, Águeda
PY  - 2021
DO  - 10.1002/ctm2.275
SN  - 2001-1326
UR  - https://hdl.handle.net/10668/27345
T2  - Clinical and translational medicine
LA  - en
KW  - Antiviral Agents
KW  - Female
KW  - Hepatitis C
KW  - Humans
KW  - Insulin Receptor Substrate Proteins
KW  - Insulin Resistance
KW  - Male
KW  - Middle Aged
KW  - Sofosbuvir
KW  - Treatment Outcome
TI  - Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation.
TY  - research article
VL  - 11
ER  -